DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) - MARKET SIZE, PREVALENCE, INCIDENCE, QUALITY OUTCOMES, TOP HOSPITALS & PHYSICIANS
Want to know more about Dexur's Capabilities? Get In Touch
Jan 2013 to Dec 2017   |   Jan 2017 to Dec 2017
CHARGE CAPTURE ANALYSIS FOR DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) GROUP BASED ON MEDICARE | |
DEMOGRAPHIC DETAILS OF DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
Race |
Total Hospitalization Volume - Jan 2017 to Dec 2017 |
% of DRG Volume |
White |
84,602 |
73.01 |
Black |
22,863 |
19.73 |
Hispanic |
3,092 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
|
Age Group ( Years ) |
Total Hospitalization Volume - Jan 2017 to Dec 2017 |
% of DRG Volume |
Greater than 84 |
28,732 |
24.8 |
Less than 65 |
22,360 |
19.3 |
80 to 84 |
16,627 |
14.35 |
|
|
|
|
|
|
|
|
|
TOP ICD DIAGNOSIS CODES FOR DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
TOP ICD PROCEDURE CODES FOR DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
TOP HOSPITALS ASSOCIATED WITH DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
TOP ATTENDING PHYSICIAN ASSOCIATED WITH DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
Physician Name |
Address |
City |
State |
Zip Code |
Total Physician & DRG Hospitalization Volume - Jan 2017 to Dec 2017 |
% of DRG Volume |
DR. RAJESH AGARWAL |
6770 MAYFIELD RD |
MAYFIELD HEIGHTS |
OH |
44124 |
73 |
0.06 |
DR. FARHAN MAQSOOD |
1100 E CHEVES ST |
FLORENCE |
SC |
29506 |
58 |
0.05 |
DR. MARCEL FILART |
3755 BEVERLY BLVD |
LOS ANGELES |
CA |
90004 |
57 |
0.05 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) SUMMARY TABLE | |
Category |
Sub Category |
DRG Group |
ICD Codes |
ICD Description |
National Projected Hospitalizations (Present on Admission - All) Jan 2016 to Dec 2016 |
Medicare Hospitalizations (Present on Admission - All) Jan 2017 to Dec 2017 |
National Projected Hospitalizations(Present on Admission - Yes) Jan 2016 to Dec 2016 |
Medicare Hospitalizations (Present on Admission - Yes) Jan 2017 to Dec 2017 |
National Projected Hospitalizations (Present on Admission - Not Y) Jan 2016 to Dec 2016 |
Medicare Hospitalizations (Present on Admission - Not Y) Jan 2017 to Dec 2017 |
Total Discharges After Exclusion |
Avg. LOS |
GMLOS |
All Cause Readmission Rate (%) |
Unplanned Readmission Rate (%) |
Total Medicare Payments |
Payment per Day |
Payment per Discharge |
Total Medicare Charges |
Avg. Charges |
Mortality Rate (%) |
SNF Discharge Rate (%) |
Home Discharge Rate (%) |
Urology |
Renal Failure |
Renal Failure |
N179 |
Acute kidney failure, unspecified |
130,713 |
87,399 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Urology |
Renal Failure |
Renal Failure |
E860 |
Dehydration |
61,136 |
47,802 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Urology |
Renal Failure |
Renal Failure |
E785 |
Hyperlipidemia, unspecified |
82,688 |
46,348 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Urology |
Renal Failure |
Renal Failure |
I2510 |
Atherosclerotic heart disease of native coronary artery without angina pectoris |
63,167 |
36,293 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Urology |
Renal Failure |
Renal Failure |
E1122 |
Type 2 diabetes mellitus with diabetic chronic kidney disease |
28,589 |
35,978 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Urology |
Renal Failure |
Renal Failure |
E875 |
Hyperkalemia |
59,053 |
31,190 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Urology |
Renal Failure |
Renal Failure |
E872 |
Acidosis |
47,217 |
28,695 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Urology |
Renal Failure |
Renal Failure |
K219 |
Gastro-esophageal reflux disease without esophagitis |
37,357 |
26,287 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Urology |
Renal Failure |
Renal Failure |
N390 |
Urinary tract infection, site not specified |
41,084 |
26,198 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Urology |
Renal Failure |
Renal Failure |
Z87891 |
Personal history of nicotine dependence |
38,853 |
25,899 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|